UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Volume overload in hemodialysis: diagnosis, cardiovascular consequences, and management

Nephrology, dialysis, transplantation, 2021-12, Vol.36 (12), p.2182-2193

2021

Volltextzugriff (PDF)

Hypernatremia and subclinical chronic kidney disease

European heart journal, 2022-11, Vol.43 (41), p.4436-4437

2022

Volltextzugriff (PDF)

Cardiovascular Events with Finerenone in CKD and Diabetes

The New England journal of medicine, 2022-04, Vol.386 (16), p.e43

2022

Volltextzugriff (PDF)

Lipid management in patients with chronic kidney disease

Nature reviews. Nephrology, 2018-12, Vol.14 (12), p.727-749

2018

Volltextzugriff (PDF)

Serum endotrophin, a type VI collagen cleavage product, is associated with increased mortality in chronic kidney disease

PloS one, 2017-04, Vol.12 (4), p.e0175200-e0175200

2017

Volltextzugriff (PDF)

Cardiovascular complications in chronic kidney disease: a review from the European Renal and Cardiovascular Medicine Working Group of the European Renal Association

Cardiovascular research, 2023-09, Vol.119 (11), p.2017-2032

2023

Volltextzugriff (PDF)

Association between periodontitis and mortality in stages 3-5 chronic kidney disease: NHANES III and linked mortality study

Journal of clinical periodontology, 2016-02, Vol.43 (2), p.104-113

2016

Volltextzugriff (PDF)

Mineralocorticoid Receptor Antagonism in Heart Failure and Chronic Kidney Disease: Short-Term Pain for Long-Term Gain

Journal of the American College of Cardiology, 2024-06, Vol.83 (24), p.2437-2439

2024

Volltextzugriff (PDF)

Hyperkalemia in Chronic Kidney Disease in the New Era of Kidney Protection Therapies

Drugs (New York, N.Y.), 2021-09, Vol.81 (13), p.1467-1489

2021

Volltextzugriff (PDF)

Hypertension Management in Patients With Autosomal Dominant Polycystic Kidney Disease: Time for a Paradigm Shift?

American journal of kidney diseases, 2020-11, Vol.76 (5), p.743-743

2020

Volltextzugriff (PDF)

Diffuse Interstitial Fibrosis and Myocardial Dysfunction in Early Chronic Kidney Disease

The American journal of cardiology, 2015-05, Vol.115 (9), p.1311-1317

2015

Volltextzugriff (PDF)

Renin-angiotensin system blockade in patients with chronic kidney disease: benefits, problems in everyday clinical use, and open questions for advanced renal dysfunction

Journal of human hypertension, 2021-06, Vol.35 (6), p.499-509

2021

Volltextzugriff (PDF)

Health-Related Quality of Life Impacts Mortality but Not Progression to End-Stage Renal Disease in Pre-Dialysis Chronic Kidney Disease: A Prospective Observational Study

PloS one, 2016-11, Vol.11 (11), p.e0165675-e0165675

2016

Volltextzugriff (PDF)

Hypertension and cardiomyopathy associated with chronic kidney disease: epidemiology, pathogenesis and treatment considerations

Journal of human hypertension, 2023-01, Vol.37 (1), p.1-19

2023

Volltextzugriff (PDF)

Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the Kidney working group of the European Society of Hypertension (ESH)

Nephrology, dialysis, transplantation, 2017-04, Vol.32 (4), p.620-640

2017

Volltextzugriff (PDF)

A novel biomarker of laminin turnover is associated with disease progression and mortality in chronic kidney disease

PloS one, 2018-10, Vol.13 (10), p.e0204239-e0204239

2018

Volltextzugriff (PDF)

Heart disease and stroke statistics 2023 update from the American Heart Association—implications for nephrology

Nephrology, dialysis, transplantation, 2024-02, Vol.39 (3), p.387-394

2024

Volltextzugriff (PDF)

SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA

Nephrology, dialysis, transplantation, 2019-02, Vol.34 (2), p.208-230

2019

Volltextzugriff (PDF)

Use of oral anticoagulants in patients with atrial fibrillation and renal dysfunction

Nature reviews. Nephrology, 2018-05, Vol.14 (5), p.337-351

2018

Volltextzugriff (PDF)

Sodium--glucose co-transporter-2 inhibitors for patients with diabetic and nondiabetic chronic kidney disease: a new era has already begun

Journal of hypertension, 2021-06, Vol.39 (6), p.1090-1097

2021

Volltextzugriff (PDF)

Quantification of fibroblast growth factor 23 and N-terminal pro-B-type natriuretic peptide to identify patients with atrial fibrillation using a high-throughput platform: A validation study

PLoS medicine, 2021-02, Vol.18 (2), p.e1003405-e1003405

2021

Volltextzugriff (PDF)

Oxidative stress links periodontal inflammation and renal function

Journal of clinical periodontology, 2021-03, Vol.48 (3), p.357-367

2021

Volltextzugriff (PDF)

Impact of renal function on survival after transcatheter aortic valve implantation (TAVI): an analysis of the UK TAVI registry

Heart (British Cardiac Society), 2015-04, Vol.101 (7), p.546-552

2015

Volltextzugriff (PDF)

Atrial Fibrillation in CKD: Balancing the Risks and Benefits of Anticoagulation

American journal of kidney diseases, 2013-09, Vol.62 (3), p.615-632

2013

Volltextzugriff (PDF)

SGLT2i for evidence-based cardiorenal protection in diabetic and non-diabetic chronic kidney disease: a comprehensive review by EURECA-m and ERBP working groups of ERA

Nephrology, dialysis, transplantation, 2023-10, Vol.38 (11), p.2444-2455

2023

Volltextzugriff (PDF)

1 – 25 von 964

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(462)
Mit Volltextzugriff
(891)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Volume overload in hemodialysis: diagnosis, cardiovascular consequences, and management

Hypernatremia and subclinical chronic kidney disease

Cardiovascular Events with Finerenone in CKD and Diabetes

Lipid management in patients with chronic kidney disease

Serum endotrophin, a type VI collagen cleavage product, is associated with increased mortality in chronic kidney disease

Cardiovascular complications in chronic kidney disease: a review from the European Renal and Cardiovascular Medicine Working Group of the European Renal Association

Association between periodontitis and mortality in stages 3-5 chronic kidney disease: NHANES III and linked mortality study

Mineralocorticoid Receptor Antagonism in Heart Failure and Chronic Kidney Disease: Short-Term Pain for Long-Term Gain

Hyperkalemia in Chronic Kidney Disease in the New Era of Kidney Protection Therapies

Hypertension Management in Patients With Autosomal Dominant Polycystic Kidney Disease: Time for a Paradigm Shift?

Diffuse Interstitial Fibrosis and Myocardial Dysfunction in Early Chronic Kidney Disease

Renin-angiotensin system blockade in patients with chronic kidney disease: benefits, problems in everyday clinical use, and open questions for advanced renal dysfunction

Health-Related Quality of Life Impacts Mortality but Not Progression to End-Stage Renal Disease in Pre-Dialysis Chronic Kidney Disease: A Prospective Observational Study

Hypertension and cardiomyopathy associated with chronic kidney disease: epidemiology, pathogenesis and treatment considerations

A novel biomarker of laminin turnover is associated with disease progression and mortality in chronic kidney disease

Heart disease and stroke statistics 2023 update from the American Heart Association—implications for nephrology

SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA

Use of oral anticoagulants in patients with atrial fibrillation and renal dysfunction

Sodium--glucose co-transporter-2 inhibitors for patients with diabetic and nondiabetic chronic kidney disease: a new era has already begun

Quantification of fibroblast growth factor 23 and N-terminal pro-B-type natriuretic peptide to identify patients with atrial fibrillation using a high-throughput platform: A validation study

Oxidative stress links periodontal inflammation and renal function

Impact of renal function on survival after transcatheter aortic valve implantation (TAVI): an analysis of the UK TAVI registry

Atrial Fibrillation in CKD: Balancing the Risks and Benefits of Anticoagulation

SGLT2i for evidence-based cardiorenal protection in diabetic and non-diabetic chronic kidney disease: a comprehensive review by EURECA-m and ERBP working groups of ERA

Suchergebnisse filtern